📰 Statement Regarding News
Page 36 - Statement Regarding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.
April 27, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2023) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology
April 27, 2023
Private Placement Announced to Support Multi-Stage Drill Program Vancouver, British Columbia--(Newsfile Corp. - April 27, 2023) - Global Battery Metals Ltd. (TSXV: GBML) (OTCQB: REZZF) (FSE: REZ) (the
April 25, 2023
Defense Metals Corp. is pleased to announce that further to the news release dated April 12, 2023, all assays for the hydrometallurgical pilot plant have been received and interpretation of the data is largely complete. Data from Phase I have been... - Veroeffentlicht am 25.04.2023
April 25, 2023
One-size-fits-allhybrid work policies are more likely than other options to have a negative impact on employee engagement, retention and the amount of work done each day, according to new hybrid work
April 25, 2023
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
April 24, 2023
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous Defence Therapeutics Inc.: DEFENCE GRANTED US PATENT WITH BROAD COVERAGE ON ACCUMTM-BASED VACCINE ENHANCER PLATFORM TECHNOLOGY 24.04.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. ___...
April 24, 2023
VANCOUVER, BC / ACCESSWIRE / April 24, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that it has signed and received payment for a development
April 24, 2023
BioNxt Secures Contract to Develop and Manufacture ODF Product for ...
April 24, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing
April 24, 2023
/CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis...